OraSure Technologies Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
11,190.00
4,614.00
8,167.00
19,720.00
30,948.00
20,396
Depreciation, Depletion & Amortization
6,552.00
6,307.00
5,696.00
5,687.00
6,402.00
6,451
Other Funds
5,572.00
5,439.00
6,602.00
6,110.00
7,104.00
15,608
Funds from Operations
162.00
7,426.00
20,513.00
30,988.00
43,805.00
41,536
Changes in Working Capital
8,223.00
100.00
4,740.00
6,390.00
15,649.00
2,446
Net Operating Cash Flow
8,385.00
7,526.00
15,773.00
24,598.00
28,156.00
39,090
Capital Expenditures
2,462.00
3,005.00
3,744.00
4,353.00
4,337.00
Purchase/Sale of Investments
-
4,975.00
2,961.00
3,712.00
92,016.00
Net Investing Cash Flow
2,462.00
7,980.00
6,705.00
8,065.00
96,353.00
Issuance/Reduction of Debt, Net
-
-
-
367.00
-
Net Financing Cash Flow
420.00
476.00
5,686.00
1,155.00
30,435.00
Net Change in Cash
5,303.00
324.00
1,227.00
15,696.00
36,921.00
Free Cash Flow
5,923.00
4,521.00
12,029.00
20,245.00
23,819.00
Deferred Taxes & Investment Tax Credit
772.00
294.00
48.00
529.00
649.00
919
Change in Capital Stock
420.00
476.00
5,686.00
788.00
30,435.00
Exchange Rate Effect
200.00
346.00
2,155.00
318.00
841.00

About OraSure Technologies

View Profile
Address
220 East 1st Street
Bethlehem Pennsylvania 18015
United States
Employees -
Website http://www.orasure.com
Updated 07/08/2019
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices.